Back to
Janus Henderson Group Ltd.
ALPN3 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in ALPINE IMMUNE SCIENCES INC
As of its Q1 2024 13F, Janus Henderson held 450,827 shares of ALPN (Alpine Immune Sciences), worth $17.8M. Janus Henderson's 13F filings listed ALPN from Q4 2023 to Q1 2024, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$11.1M
Total Shares Change
-583,239
Quarter-by-Quarter History
Other major holders of ALPN: Avoro Capital Advisors LLC, BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.